POST-POLYCYTHEMIA VERA RELATED MYELOFIBROSIS

Clinical trials for POST-POLYCYTHEMIA VERA RELATED MYELOFIBROSIS explained in plain language.

Never miss a new study

Get alerted when new POST-POLYCYTHEMIA VERA RELATED MYELOFIBROSIS trials appear

Sign up with your email to follow new studies for POST-POLYCYTHEMIA VERA RELATED MYELOFIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New injection trial targets rare blood cancer symptoms

Disease control Recruiting now

This study is testing whether canakinumab, an anti-inflammatory injection given every 3 weeks, can help control myelofibrosis. Researchers want to see if it reduces symptoms like fatigue and enlarged spleen, improves anemia, and is safe for patients. The trial is for adults with …

Matched conditions: POST-POLYCYTHEMIA VERA RELATED MYELOFIBROSIS

Phase: PHASE2 • Sponsor: John Mascarenhas • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

POST-POLYCYTHEMIA VERA RELATED MYELOFIBROSIS

Get alerted when new POST-POLYCYTHEMIA VERA RELATED MYELOFIBROSIS trials appear

New injection trial targets rare blood cancer symptoms